Bodo Lange
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bodo Lange has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Heike Küster
Riemser Arzneimittel AG, An der Wiek 7, 17493, Greifswald-Insel Riems, Germany
1 shared publication - Immanuel Leifer
Institute of Virology and Immunoprophylaxis (IVI), Sensemattstrasse 293, 3147, Mittelhaeusern, Switzerland
1 shared publication - Martin Beer
Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald - Insel Riems, Germany
1 shared publication - Patricia König
Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493, Greifswald-Insel Riems, Germany
1 shared publication - Sandra Blome
Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald-Insel Riems, Germany
1 shared publication - Ulrike Blohm
Institut für Immunologie, Friedrich-Loeffler-Institut, Südufer 10, Greifswald-Insel Riems, Germany
1 shared publication
Latest Publications
- Open Access
- 20 April 2012
- Published by Springer Nature in Veterinary Research
- Vol. 43 (1) , 33
Characterization of C-strain “Riems” TAV-epitope escape variants obtained through selective antibody pressure in cell culture
Classical swine fever virus (CSFV) C-strain “Riems” escape variants generated under selective antibody pressure with monoclonal antibodies and a peptide-specific antiserum in cell culture were investigated. Candidates with up to three amino acid exchanges in the immunodominant and highly conserved linear TAV-epitope of the E2-glycoprotein, and additional mutations in the envelope proteins ERNS and E1, were characterized both in vitro and in vivo. It was further demonstrated, that intramuscular immunization of weaner pigs with variants selected after a series of passages elicited full protection against lethal CSFV challenge infection. These novel CSFV C-strain variants with exchanges in the TAV-epitope present potential marker vaccine candidates. The DIVA (differentiating infected from vaccinated animals) principle was tested for those variants using commercially available E2 antibody detection ELISA. Moreover, direct virus differentiation is possible using a real-time RT-PCR system specific for the new C-strain virus escape variants or using differential immunofluorescence staining.
- 20 April 2012
- Published by Springer Nature in Veterinary Research
- Vol. 43 (1) , 33
Open AccessCharacterization of C-strain “Riems” TAV-epitope escape variants obtained through selective antibody pressure in cell culture
Classical swine fever virus (CSFV) C-strain “Riems” escape variants generated under selective antibody pressure with monoclonal antibodies and a peptide-specific antiserum in cell culture were investigated. Candidates with up to three amino acid exchanges in the immunodominant and highly conserved linear TAV-epitope of the E2-glycoprotein, and additional mutations in the envelope proteins ERNS and E1, were characterized both in vitro and in vivo. It was further demonstrated, that intramuscular immunization of weaner pigs with variants selected after a series of passages elicited full protection against lethal CSFV challenge infection. These novel CSFV C-strain variants with exchanges in the TAV-epitope present potential marker vaccine candidates. The DIVA (differentiating infected from vaccinated animals) principle was tested for those variants using commercially available E2 antibody detection ELISA. Moreover, direct virus differentiation is possible using a real-time RT-PCR system specific for the new C-strain virus escape variants or using differential immunofluorescence staining.